Rs548234 polymorphism at PRDM1-ATG5 region susceptible to rheumatoid arthritis in caucasians is not associated with rheumatoid arthritis in Chinese han population

Chinese Medical Journal

Volumn 124, Issue 18, 2011, Pages 2863-2867

  Lu, Iao Lan ^a   Zhou, Xu Jie ^b   Guo, Jian Ping ^a   Jia, Ru Lin ^a   Zhao, Yi ^c   Jiang, Quan ^d   Liu, Xiang Yuan ^e   Liu, Yi ^f   Sun, Ling Yun ^g   Zhang, Hong ^b   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^e PEKING UNIVERSITY THIRD HOSPITAL   (China)

^f SICHUAN UNIVERSITY   (China)

^g MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Chinese han population; Genetic association; PRDM1 ATG5; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GENOMIC DNA; RHEUMATOID FACTOR;

ADULT; ARTICLE; CAUCASIAN; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS;

EID: 80053032977     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.18.012     Document Type: Article

References (35)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-1289.
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-37.
3. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976; 57: 1148-1157.
4. Clarke A, Vyse TJ. Genetics of rheumatic disease. Arthritis Res Ther 2009; 11: 248.
5. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008; 4: e1000024.
6. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989; 36: 178-182.
7. Rigby AS, Silman AJ, Voelm L, Gregory JC, Ollier WE, Khan MA, et al. Investigating the HLA component in rheumatoid arthritis: an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 1991; 8: 153-175.
8. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998; 95: 10746-10750.
9. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
10. Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL, et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009; 41: 820-823.
11. Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, Takahashi A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010; 42: 515-519.
12. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209.
13. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216-1223.
14. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009; 41: 1313-1318.
15. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-514.
16. Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006; 18: 214-223.
17. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-3447.
18. Calame K. Activation-dependent induction of Blimp-1. Curr Opin Immunol 2008; 20: 259-264.
19. Crotty S, Johnston RJ, Schoenberger SP. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol 2010; 11: 114-120.
20. Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008; 26: 133-169.
21. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, et al. The role of autophagy during the early neonatal starvation period. Nature 2004; 432: 1032-1036.
22. Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol 2009; 10: 461-470.
23. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007; 7: 767-777.
24. Munz C. Enhancing immunity through autophagy. Annu Rev Immunol 2009; 27: 423-449.
25. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
26. Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. Ethnic differences in allele frequency of autoimmunedisease-associated SNPs. J Hum Genet 2005; 50: 264-266.
27. Zhang ZH, Chen F, Zhang XL, Jin Y, Bai J, Fu SB. PTPN22 allele polymorphisms in 15 Chinese populations. Int J Immunogenet 2008; 35: 433-437.
28. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der Helm-van Mil AH, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80: 867-875.
29. Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2006; 2: 425-433.
30. Ikari K, Kuwahara M, Nakamura T, Momohara S, Hara M, Yamanaka H, et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 2005; 52: 3054-3057.
31. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006; 54: 90-96.
32. Burr ML, Naseem H, Hinks A, Eyre S, Gibbons LJ, Bowes J, et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2010; 69: 666-670.
33. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-1060.
34. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67: 1488-1492.
35. Mei L, Li X, Yang K, Cui J, Fang B, Guo X, et al. Evaluating gene x gene and gene x smoking interaction in rheumatoid arthritis using candidate genes in GAW15. BMC Proc 2007; 1 Suppl 1: s17.